Negative regulation of chemokine receptor signaling and B-cell chemotaxis by p66Shc
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Negative regulation of chemokine receptor signaling and B-cell chemotaxis by p66Shc
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 5, Issue 2, Pages e1068-e1068
Publisher
Springer Nature
Online
2014-02-20
DOI
10.1038/cddis.2014.44
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Chemokine CXCL12 Generates Costimulatory Signals in T Cells to Enhance Phosphorylation and Clustering of the Adaptor Protein SLP-76
- (2013) X. Smith et al. Science Signaling
- S1P1 expression is controlled by the pro-oxidant activity of p66Shc and is impaired in B-CLL patients with unfavorable prognosis
- (2012) N. Capitani et al. BLOOD
- SLP-76 is required for optimal CXCR4-stimulated T lymphocyte firm arrest to ICAM-1 under shear flow
- (2012) Dooyoung Lee et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Redox regulation of cell migration and adhesion
- (2012) Thomas Ryan Hurd et al. TRENDS IN CELL BIOLOGY
- Novel role of p66Shc in ROS-dependent VEGF signaling and angiogenesis in endothelial cells
- (2011) Jin Oshikawa et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Enzymatic and non-enzymatic activities of SHIP-1 in signal transduction and cancer
- (2011) Claude Condé et al. BIOCHEMICAL PHARMACOLOGY
- Rho GTPases: Masters of T lymphocyte migration and activation
- (2011) Pablo Rougerie et al. IMMUNOLOGY LETTERS
- p66Shc Is a Negative Regulator of Fc RI-Dependent Signaling in Mast Cells
- (2011) C. Ulivieri et al. JOURNAL OF IMMUNOLOGY
- Role of stromal microenvironment in nonpharmacological resistance of CML to imatinib through Lyn/CXCR4 interactions in lipid rafts
- (2011) Y Tabe et al. LEUKEMIA
- Spleen tyrosine kinase inhibition prevents chemokine- and integrin-mediated stromal protective effects in chronic lymphocytic leukemia
- (2010) M. Buchner et al. BLOOD
- Impaired expression of p66Shc, a novel regulator of B-cell survival, in chronic lymphocytic leukemia
- (2010) N. Capitani et al. BLOOD
- Cyclic AMP-mediated immune regulation — Overview of mechanisms of action in T cells
- (2010) Randi Mosenden et al. CELLULAR SIGNALLING
- CXCL12 (SDF-1)/CXCR4 Pathway in Cancer
- (2010) B. A. Teicher et al. CLINICAL CANCER RESEARCH
- Unique and redundant functions of integrins in the epidermis
- (2010) Coert Margadant et al. FASEB JOURNAL
- Finding the right niche: B-cell migration in the early phases of T-dependent antibody responses
- (2010) J. P. Pereira et al. INTERNATIONAL IMMUNOLOGY
- HPK1 Associates with SKAP-HOM to Negatively Regulate Rap1-Mediated B-Lymphocyte Adhesion
- (2010) Sebastian Königsberger et al. PLoS One
- Novel Role of NADPH Oxidase in Angiogenesis and Stem/Progenitor Cell Function
- (2009) Masuko Ushio-Fukai et al. ANTIOXIDANTS & REDOX SIGNALING
- Positive and negative regulation of antigen receptor signaling by the Shc family of protein adapters
- (2009) Francesca Finetti et al. IMMUNOLOGICAL REVIEWS
- Src Homology 2-Domain Containing Leukocyte-Specific Phosphoprotein of 76 kDa Is Mandatory for TCR-Mediated Inside-Out Signaling, but Dispensable for CXCR4-Mediated LFA-1 Activation, Adhesion, and Migration of T Cells
- (2009) J. Horn et al. JOURNAL OF IMMUNOLOGY
- Phosphoinositide 3-Kinase p110 Regulates Natural Antibody Production, Marginal Zone and B-1 B Cell Function, and Autoantibody Responses
- (2009) C. A. Durand et al. JOURNAL OF IMMUNOLOGY
- Intraflagellar transport is required for polarized recycling of the TCR/CD3 complex to the immune synapse
- (2009) Francesca Finetti et al. NATURE CELL BIOLOGY
- The proapoptotic and antimitogenic protein p66SHC acts as a negative regulator of lymphocyte activation and autoimmunity
- (2008) F. Finetti et al. BLOOD
- Intracellular mediators of CXCR4-dependent signaling in T cells
- (2007) Laura Patrussi et al. IMMUNOLOGY LETTERS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started